Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
09/2010
09/07/2010US7790170 Transgenic plant comprising expression vector coding mannheimia modified toxin protein for use in preparing vaccine against respiratory infection in domestic animals; veterinary medicine
09/07/2010US7790166 Anti-CD40 antibodies capable of blocking B-cell activation
09/07/2010US7790155 Calbindin-D28K protection against glucocorticoid induced cell death
09/07/2010US7790144 Receptor-avid exogenous optical contrast and therapeutic agents
09/07/2010CA2608864C Recombinant mva virus, and the use thereof
09/07/2010CA2596274C Recombinant mva virus, and the use thereof
09/07/2010CA2453112C New cationic peptides of the dermaseptin family isolated from the skin secretion of phyllomedusa hypochondrialls
09/07/2010CA2450871C Assay for identifying inhibitors of hiv rt dimerization
09/07/2010CA2277999C The 74 kilodalton outer membrane protein from moraxella catarrhalis
09/07/2010CA2259156C Truncated soluble tumor necrosis factor type-i and type-ii receptors
09/07/2010CA2231774C Plants which synthesize a modified starch, process for the production thereof and modified starch
09/07/2010CA2226177C Analogs of parathyroid hormone
09/07/2010CA2179895C Marker for pathologies comprising an auto-immune reaction and/or for inflammatory diseases
09/02/2010WO2010099515A2 Apparatus, system, and method for creating immunologically enhanced spaces in-vivo
09/02/2010WO2010099472A2 Spanx-b polypeptides and their use
09/02/2010WO2010099432A2 Recognition of cyp2e1 epitopes
09/02/2010WO2010099401A1 Calcium signaling modulators involving stim and orai proteins
09/02/2010WO2010099394A1 Alteration and modulation of protein activity by varying post-translational modification
09/02/2010WO2010099365A2 Pesticidal proteins and methods for their use
09/02/2010WO2010099219A2 Designer ligands of tgf-beta superfamily
09/02/2010WO2010099079A1 Antibodies to troponin i and methods of use thereof
09/02/2010WO2010099019A1 Antibodies containing therapeutic tpo/epo mimetic peptides
09/02/2010WO2010098788A2 Pd-i antagonists and methods for treating infectious disease
09/02/2010WO2010098682A1 Cell marker for melanocyte lineage and cancer cells and uses thereof
09/02/2010WO2010098421A1 Recombinant human bone morphogenetic protein having improved storage stability
09/02/2010WO2010098079A1 Method for denucleating nucleated erythrocyte, and denucleation inducer
09/02/2010WO2010097746A1 Metallothionein gene conferring abiotic stress tolerance in plants and uses thereof
09/02/2010WO2010097709A2 Polypeptides for the prevention or treatment of malaria
09/02/2010WO2010097462A1 Cellobiose dehydrogenase
09/02/2010WO2010097343A1 Plants having enhanced yield-related traits and a method for making the same
09/02/2010WO2010097182A1 Method for in vivo imaging of lymph node lymphangiogenesis by immuno-positron emission tomography and markers therefore
09/02/2010WO2010097066A1 Serine protease inhibitors for the specific inhibition of tissue kallikreins
09/02/2010WO2010096874A1 Use of benzodioxole derivatives and bt toxins in the control of pets
09/02/2010WO2010075548A3 Immunoglobulin variants with altered binding to protein a
09/02/2010WO2010053816A3 Biomarkers for diagnosis of breast cancer
09/02/2010WO2010053584A3 Compositions and methods for modulating cell-cell fusion via intermediate-conductance calcium-activated potassium channels
09/02/2010WO2010042760A3 Compositions, methods, and kits for enhancing the immunogenicity of pathogenic antigens
09/02/2010WO2010040136A4 Selection of hiv vaccine antigens by use of intrapatient sequence variation to identify mutations in the hiv envelope glycoprotein that affect the binding of broadly neutralizing antibodies
09/02/2010WO2010028066A3 Cd133 epitopes
09/02/2010WO2010006772A8 Use of cd95 inhibitors for the treatment of inflammatory disorders
09/02/2010WO2009047474A3 Modified growth hormone polypeptides
09/02/2010WO2008132494A8 Truncated variant of the mammalian target for rapamycin (mtor) protein
09/02/2010US20100223696 Maize Cellulose Synthases and Uses Thereof
09/02/2010US20100223695 NAC Transcriptional Activators Involved in Abiotic Stress Tolerance
09/02/2010US20100223692 Transgenic Plants with Increased Stress Tolerance and Yield
09/02/2010US20100223688 Generation of plants with improved pathogen resistance
09/02/2010US20100223684 Humanin receptor or humanin-like polypeptide receptor
09/02/2010US20100223678 protein isoforms of the pif-family and uses thereof
09/02/2010US20100222558 Process for protein extraction
09/02/2010US20100222557 Cytokine zalpha11ligand antibodies
09/02/2010US20100222556 Antibodies to cytokine receptor zalpha11
09/02/2010US20100222555 Monoclonal antibodies that neutralize botulinum neurotoxin
09/02/2010US20100222553 Spider silk dragline polynucleotides, polypeptides and methods of use thereof
09/02/2010US20100222552 Production and purification of il-29
09/02/2010US20100222551 Highly thermostable fluorescent proteins
09/02/2010US20100222550 Compstatin analogs with improved activity
09/02/2010US20100222546 Methods for the preparation of functionalized peptides, proteins and carbohydrates and their conjugates
09/02/2010US20100222438 Methods compositions and article of manufacture for modulating bone growth
09/02/2010US20100222424 Method of Screening Drug with the Use of 67 kDa Laminin Receptor and Drug Obtained Thereby
09/02/2010US20100222401 Compositions and methods for treating pathologic angiogenesis and vascular permeability
09/02/2010US20100222277 Regulation of Food Preference Using GLP-1 Agonists
09/02/2010US20100222276 protease-sensitive site in apolipoprotein a1, therapeutic and diagnostic implications
09/02/2010US20100222275 Therapeutic agent for vitiligo and method of accelerating pigmentation
09/02/2010US20100222274 Glycosylation-deficient hepatocyte growth factor
09/02/2010US20100222273 Modified cry35 proteins
09/02/2010US20100222269 Improved derivatives of amylin
09/02/2010US20100222268 Antibiotic peptides
09/02/2010US20100222267 Recombinant transferrin mutants
09/02/2010US20100222266 Cytokine receptor protein for use in identifying modulators which prevent hepatitis viral replication and infection; viricides
09/02/2010US20100222264 Use of rgd-enriched gelatine-like proteins for inhibition of cancer metastasis
09/02/2010US20100222263 Atap peptides, nucleic acids encoding the same and associated methods of use
09/02/2010US20100222261 Peptidic antagonists of class iii semaphorins/neuropilins complexes
09/02/2010US20100222258 TNF antagonist and TNF inhibitor containing it as an effective ingredient
09/02/2010US20100222254 Stabilization of clostridium botulinum neurotoxin complex
09/02/2010US20100222253 Methods for extracting platelets and compositions obtained therefrom
09/02/2010US20100222237 Methods for Generating Polynucleotides Having Desired Characteristics by Iterative Selection and Recombination
09/02/2010US20100222236 Multiple antigenic peptide assay for detection of hiv or siv type retroviruses
09/02/2010US20100221844 Caustic stable chromatography ligands
09/02/2010US20100221840 Methods for testing for and inhibiting the development of huntington's disease
09/02/2010US20100221822 Humanized and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria
09/02/2010US20100221820 Use of triplex structure DNA in transferring nucleotide sequences
09/02/2010US20100221810 Novel diglycosidase and gene encoding the same
09/02/2010US20100221799 Reductase, gene thereof and method of using the same
09/02/2010US20100221782 Modified Chimeric Polypeptides With Improved Pharmacokinetic Properties
09/02/2010US20100221779 Phytases, nucleic acids encoding them and methods for making and using them
09/02/2010US20100221777 Designer ligands of tgf-beta superfamily
09/02/2010US20100221775 Increased production of secreted proteins by recombinant eukaryotic cells
09/02/2010US20100221753 Prostate Cancer-Related Compositions, Methods and Kits Based on DNA Macroarray Proteomics Platforms
09/02/2010US20100221745 Abnormal prion protein binder, and method for detection of abnormal prion protein
09/02/2010US20100221737 Translocation and Mutant ROS Kinase in Human Non-Small Cell Lung Carcinoma
09/02/2010US20100221724 Patched polypeptides and uses related thereto
09/02/2010US20100221714 Analysis and use of par1 polymorphisms for evaluating the risk of cardiovascular disease
09/02/2010US20100221362 Stable amorphous calcium carbonate comprising synthetic phosphorylated peptides
09/02/2010US20100221288 Novel streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof
09/02/2010US20100221287 Streptococcus pneumoniae Polynucleotides and Sequences
09/02/2010US20100221283 Circovirus sequences associated with piglet weight loss disease (pwd)
09/02/2010US20100221280 Plant-produced compositions for treating papillomavirus infection and related methods
09/02/2010US20100221278 Immunogenic compositions for streptococcus pyogenes
09/02/2010US20100221277 Chlamydia pneumoniae antigens
09/02/2010US20100221276 Circovirus sequences associated with piglet weight loss disease (pwd)
1 ... 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 ... 2916